About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Colorectal Cancer Clinical Trials in Dallas | 219 Studies

Clinical Trials Colorectal CancerDallas

Colorectal Cancer Clinical Trials in Dallas

Find 219 clinical trials for colorectal cancer near Dallas, Texas. Connect with research centers in your area.

All Colorectal Cancer trials nationwide All trials in Dallas

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 81-100 of 219 trials

CompletedStudy Of Sunitinib Plus FOLFOX In Patients With Solid TumorsThis study determined the maximum tolerated dose and safety of SU011248 (sunitinib malate, SUTENT) in combination with FOLFOX \[Leucovorin + Fluorouracil (5-FU) + Oxaliplatin\].NCT00599924·Aurora, Colorado and 2 others Active not recruitingA Study Investigating the Efficacy and Safety of Alcestobart (LBL-007) Plus Tislelizumab in Combination With Bevacizumab Plus Fluoropyrimidine Versus Bevacizumab Plus Fluoropyrimidine in Participants With Unresectable or Metastatic Colorectal CancerThis is a Phase 1b/2 study to investigate the efficacy and safety of alcestobart (LBL-007) plus tislelizumab when administered in combination with bevacizumab plus…NCT05609370·Anchorage, Alaska and 63 others

Colorectal Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedEpidemiological Study to Monitor Study Participants With Resected Stage II (High Risk) or Stage III Colorectal Cancer for Circulating Tumor DNA Before, During and After Their Treatment With Adjuvant ChemotherapyThis is a multi-site epidemiological study designed to monitor circulating tumor DNA (ctDNA) status in participants with Stage II (high risk)/III colorectal cancer (CRC) following…NCT04813627·California City, California and 73 others

CompletedCetuximab, Bevacizumab & 5FU/Leucovorin vs. Oxaliplatin, Bevacizumab & 5FU/Leucovorin in Metastatic Colorectal CancerThe purpose of this study is to compare the rates of Progression-Free Survival (PFS) at 12 months for patients treated with Bev-FOLFOX versus patients treated with FOLF-CB for…NCT00252564·Birmingham, Alabama and 81 others

CompletedLaparoscopic-Assisted Surgery Compared With Open Surgery in Treating Patients With Colon CancerRATIONALE: Less invasive types of surgery may help reduce the number of side effects and improve recovery.NCT00002575·Huntsville, Alabama and 157 others

UnknownPROSPECT: Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer Undergoing SurgeryThe standard treatment for locally advanced rectal cancer involves chemotherapy and radiation, known as 5FUCMT, (the chemotherapy drugs 5-fluorouracil/capecitabine and radiation…NCT01515787·Birmingham, Alabama and 1072 others

CompletedYttrium Y 90 Resin Microspheres Data Collection in Unresectable Liver Cancer: the RESIN StudyThis research registry studies Yttrium Y 90 resin microspheres in collecting data from patients with liver cancer not capable of being removed by surgery (unresectable) for the…NCT02685631·Birmingham, Alabama and 41 others

TerminatedA Phase 1a/1b FIH Study of PY159 and in Combination With Pembrolizumab in Subjects With Advanced Solid TumorsThis is an open-label, multicenter, First-In-Human (FIH), Phase 1a/1b study of PY159 in subjects with locally advanced (unresectable) and/or metastatic solid tumors that are…NCT04682431·Los Angeles, California and 16 others

CompletedA Study of CTX-009 in Adult Patients With Metastatic Colorectal CancerThis study is designed as an open-label, adaptive Simon Two-Stage study to evaluate the efficacy of CTX-009 in patients with metastatic colorectal cancer.NCT05513742·Hot Springs, Arkansas and 6 others

CompletedA Study of ABT-165 in Subjects With Solid TumorsThis is a Phase 1/1b open-label study evaluating the safety, pharmacokinetics (PK), and preliminary efficacy of ABT-165 when administered as monotherapy and in combination with…NCT01946074·Scottsdale, Arizona and 9 others

Active not recruitingEvaluation of Co-formulated Pembrolizumab/Quavonlimab (MK-1308A) Versus Other Treatments in Participants With Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Stage IV Colorectal Cancer (CRC) (MK-1308A-008/KEYSTEP-008).The purpose of this study is to assess the efficacy and safety of co-formulated pembrolizumab/quavonlimab versus other treatments in participants with MSI-H or dMMR Metastatic…NCT04895722·Orange City, Florida and 108 others

Active not recruitingColonoscopy Versus Fecal Immunochemical Test in Reducing Mortality From Colorectal Cancer (CONFIRM)Colorectal cancer (CRC) is currently the second most common cause of cancer death in the United States, and one of the most preventable cancers.NCT01239082·Phoenix, Arizona and 45 others

CompletedA Study of XmAb®23104 in Subjects With Selected Advanced Solid Tumors (DUET-3)This is a Phase 1, multiple dose, ascending dose escalation study to define a MTD/RD and regimen of XmAb23104, to describe safety and tolerability, to assess PK and…NCT03752398·San Diego, California and 17 others

RecruitingOpen-Label Study of BBO-10203 in Subjects With Advanced Solid TumorsFirst in human study to evaluate the safety, tolerability, and pharmacokinetics (PK) of BBO-10203, a PI3Kα:RAS breaker, alone and in combination with other anti-cancer agents in…NCT06625775·Duarte, California and 43 others

CompletedStudy of NGM120 in Subjects With Advanced Solid Tumors, Pancreatic Cancer, and Prostate Cancer Using Combination TherapyStudy of NGM120 in subjects with advanced solid tumors and pancreatic cancer (Part 1 and 2) and metastatic castration resistant prostate cancer (Part 3).NCT04068896·Tucson, Arizona and 19 others

Active not recruitingA Study of TSR-022 in Participants With Advanced Solid Tumors (AMBER)This is a first-in-human study evaluating the anti-T cell immunoglobulin and mucin containing protein-3 (TIM-3) antibody TSR-022.NCT02817633·Goodyear, Arizona and 88 others

RecruitingA Study to Assess Adverse Events, Change in Disease Activity and How Intravenous ABBV-253 Moves Through the Body in Adult Participants With Advanced Solid TumorsCancer is a condition where cells in a specific part of body grow and reproduce uncontrollably.NCT07807956·Grand Rapids, Michigan and 2 others

Active not recruitingPhase 3 Study of MRTX849 With Cetuximab vs Chemotherapy in Patients With Advanced Colorectal Cancer With KRAS G12C Mutation (KRYSTAL-10)Study CA239-0006 is an open-label, randomized Phase 3 clinical trial comparing the efficacy of MRTX849 administered in combination with cetuximab versus chemotherapy in the…NCT04793958·Alabaster, Alabama and 418 others

CompletedPhase Ib, Dose Escalation Study of Oral LDE225 in Combination With BKM120 in Patients With Advanced Solid TumorsThe purpose of this study is to determine the maximum dose of LDE225 and BKM120 that can be safely given together to patients and/or the dose that will be used in future studies.NCT01576666·Los Angeles, California and 22 others

CompletedLong-term Follow-up Study Designed to Evaluate the Relative Risk of Two Colonoscopy Schedules for Patients With Small PolypsColorectal cancer is a leading cause of cancer death in the United States.NCT00032344·Phoenix, Arizona and 12 others

PreviousPage 5 of 11Next

Other Conditions in Dallas

Breast Cancer Lung Cancer Prostate Cancer Melanoma Leukemia Lymphoma